Familial and sporadic hemiplegic migraine;Migraine hémiplégique familiale et sporadique

Revue Neurologique

Volumn 164, Issue 3, 2008, Pages 216-224

  Ducros, A ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

ATP1A2; Aura; Autosomal dominant; CACNA1A; Cerebellar ataxia; Coma; Epilepsy; Familial hemiplegic migraine; Hemiplegia; Ion channel; Migraine; SCN1A; Sporadic hemiplegic migraine

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIPYRETIC ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETIRACETAM; GABAPENTIN; KETAMINE; LAMOTRIGINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREGABALIN; PROPRANOLOL; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

ATAXIA; ATP1A2 GENE; CACNA1A GENE; CEREBELLUM; CLINICAL FEATURE; COMA; CONFUSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSARTHRIA; FAMILIAL HEMIPLEGIC MIGRAINE; FAMILY HISTORY; FEVER; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEMIPLEGIA; HUMAN; INTELLECTUAL IMPAIRMENT; MIGRAINE AURA; MOTOR DYSFUNCTION; NYSTAGMUS; OXYGEN THERAPY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PROPHYLAXIS; REVIEW; SCNA1 GENE; SEIZURE; SENSORY DYSFUNCTION; SPEECH DISORDER; SPORADIC HEMIPLEGIC MIGRAINE; TREATMENT CONTRAINDICATION; VISUAL DISORDER; WEAKNESS; GENETICS; MIGRAINE WITH AURA;

HUMANS; MIGRAINE WITH AURA; PROGNOSIS;

EID: 45849146538     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2007.10.003     Document Type: Review

References (22)

1. Classification committee of the International Headache Society. The international classification of headache disorders. Cephalalgia 24 (2004) 1-160
2. D'Andrea G., Granella F., Cadaldini M., and Manzoni G.C. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 119 (1999) 64-66
3. De Fusco M., Marconi R., Silvestri L., et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics 33 (2003) 192-196
4. Dichgans M., Freilinger T., Eckstein G., et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366 (2005) 371-377
5. Ducros A., Denier C., Joutel A., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. The New England Journal of Medecine 345 (2001) 17-24
6. Ducros A., and Thomsen L.L. Familial hemiplegic migraine. In: Olesen J., Tfelt-Hansen P., and Welch K.M.A. (Eds). The headaches. 3rd ed. (2005), Lippincott-Raven Publishers, N.Y.C.: New York 577-587
7. Ducros A. Génétique de la migraine - Migraine hémiplégique familiale. In: Bousser M.G., Ducros A., and Massiou H. (Eds). Migraine et céphalées (2005), Doin, Paris 47-64
8. Ducros A. Hemiplegic migraine: Clinical features, links with basilar-type migraine, current and future treatment. Headache Currents 3 (2006) 86-96
9. Kors E.E., Haan J., Giffin N.J., et al. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Archives of Neurology 60 (2003) 684-688
10. Kors E.E., Terwindt G.M., Vermeulen F.L., et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Annals of Neurology 49 (2001) 753-760
11. Lampl C., Buzath A., Klinger D., and Neumann K. Lamotrigine in the prophylactic treatment of migraine aura--a pilot study. Cephalalgia 19 (1999) 58-63
12. Lampl C., Katsarava Z., Diener H.C., and Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. Journal of Neurology, Neurosurgery, and Psychiatry 76 (2005) 1730-1732
13. Moskowitz M.A., Bolay H., and Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Annals of Neurology 55 (2004) 276-280
14. O'Hare J.A., Feely M.J., and Callaghan N. Clinical aspects of familial hemiplegic migraine in two families. Irish Medical Journal 74 (1981) 291-295
15. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
16. Thomsen L.L., Eriksen M.K., Roemer S.F., Andersen I., Olesen J., and Russell M.B. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 125 (2002) 1379-1391
17. Thomsen L.L., Eriksen M.K., Romer S.F., et al. An epidemiological survey of hemiplegic migraine. Cephalalgia 22 (2002) 361-375
18. Thomsen L.L., Ostergaard E., Olesen J., and Russell M.B. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 60 (2003) 595-601
19. Tottene A., Pivotto F., Fellin T., Cesetti T., van den Maagdenberg A.M., and Pietrobon D. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. The Journal of Biological Chemistry 280 (2005) 17678-17686 [Epub 12005 Mar 17672]
20. van den Maagdenberg A.M., Pietrobon D., et al. A CACNA1A knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 (2004) 701-710
21. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Annals of Neurology 54 (2003) 360-366
22. Vanmolkot K.R., Stroink H., Koenderink J.B., et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Annals of Neurology 59 (2006) 310-314